FANG-TSYRLINFANG-TSYR LIN0.000000000000000.000000000000003942LIN, FANG-TSYRAssociate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 1051817Experimental Radiation OncologyGynecological Oncology & Reproductive MedicineMolecular & Cellular OncologySystems BiologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorGORDON BMILLSGORDON B MILLS8620MILLS, GORDON BProfessorJUNJIECHENJUNJIE CHEN8830CHEN, JUNJIEProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessor15075294Liu K, Luo Y, Lin FT, Lin WCGenes & developmentTopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival. Genes Dev. 2004 Mar 15; 18(6):673-86.Genes Dev2004-03-15T00:00:002004TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.15226443Luo Y, Lin FT, Lin WCMolecular and cellular biologyATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage. Mol Cell Biol. 2004 Jul; 24(14):6430-44.Mol Cell Biol2004-07-01T00:00:002004ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.74Professor10Assistant Professor54Instructor14Associate Professor3Adjunct Associate Professor6Adjunct ProfessorOne Baylor PlazaHouston, 77030TXAMANDAROSEWELL SHAWAMANDA ROSEWELL SHAW0.000000000000000.000000000000004995ROSEWELL SHAW, AMANDAAssistant Professor15494392Wang B, Liu K, Lin FT, Lin WCThe Journal of biological chemistryA role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis. J Biol Chem. 2004 Dec 24; 279(52):54140-52.J Biol Chem2004-10-19T00:00:002004A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis.17006541Liu K, Paik JC, Wang B, Lin FT, Lin WCThe EMBO journalRegulation of TopBP1 oligomerization by Akt/PKB for cell survival. EMBO J. 2006 Oct 18; 25(20):4795-807.EMBO J2006-09-28T00:00:002006Regulation of TopBP1 oligomerization by Akt/PKB for cell survival.17965021Lin FT, Lai YJ, Makarova N, Tigyi G, Lin WCThe Journal of biological chemistryThe lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. J Biol Chem. 2007 Dec 28; 282(52):37759-69.J Biol Chem2007-10-26T00:00:002007The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival.17591779Lai YJ, Lin WC, Lin FTThe Journal of biological chemistryPTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration. J Biol Chem. 2007 Aug 17; 282(33):24381-7.J Biol Chem2007-06-25T00:00:002007PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.18660752Yang SZ, Lin FT, Lin WCEMBO reportsMCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis. EMBO Rep. 2008 Sep; 9(9):907-15.EMBO Rep2008-07-25T00:00:002008MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.27134758Lin FT, Lin VY, Lin VT, Lin WCCell discoveryTRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation. Cell Discov. 2016; 2.Cell Discov2016-03-01T00:00:002016TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation.23339869Lin VT, Lin VY, Lai YJ, Chen CS, Liu K, Lin WC, Lin FTMolecular and cellular biologyTRIP6 regulates p27 KIP1 to promote tumorigenesis. Mol Cell Biol. 2013 Apr; 33(7):1394-409.Mol Cell Biol2013-01-22T00:00:002013TRIP6 regulates p27 KIP1 to promote tumorigenesis.28439015Liu K, Lin FT, Graves JD, Lee YJ, Lin WCProceedings of the National Academy of Sciences of the United States of AmericaMutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin. Proc Natl Acad Sci U S A. 2017 05 09; 114(19):E3766-E3775.Proc Natl Acad Sci U S A2017-04-24T00:00:002017Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.12697828Liu K, Lin FT, Ruppert JM, Lin WCMolecular and cellular biologyRegulation of E2F1 by BRCT domain-containing protein TopBP1. Mol Cell Biol. 2003 May; 23(9):3287-304.Mol Cell Biol2003-05-01T00:00:002003Regulation of E2F1 by BRCT domain-containing protein TopBP1.14688263Xu J, Lai YJ, Lin WC, Lin FTThe Journal of biological chemistryTRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. J Biol Chem. 2004 Mar 12; 279(11):10459-68.J Biol Chem2003-12-18T00:00:002003TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.15988003Lai YJ, Chen CS, Lin WC, Lin FTMolecular and cellular biologyc-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration. Mol Cell Biol. 2005 Jul; 25(14):5859-68.Mol Cell Biol2005-07-01T00:00:002005c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.22580462Budhavarapu VN, White ED, Mahanic CS, Chen L, Lin FT, Lin WCCell cycle (Georgetown, Tex.)Regulation of E2F1 by APC/C Cdh1 via K11 linkage-specific ubiquitin chain formation. Cell Cycle. 2012 May 15; 11(10):2030-8.Cell Cycle2012-05-15T00:00:002012Regulation of E2F1 by APC/C Cdh1 via K11 linkage-specific ubiquitin chain formation.true1Associate ProfessorAssociate Professortrue1InstructorInstructortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorD019390Chemicals & Drugs19460.979916ArrestinsD048868Chemicals & Drugs64914280.606332Adaptor Proteins, Signal TransducingD008246Chemicals & Drugs471470.922224LysophospholipidsD014157Chemicals & Drugs126352660.358195Transcription FactorsDepartment of MedicineDepartment of Molecular & Cellular BiologyDepartment of Pathology & ImmunologyMedicine-Hematology & OncologyMolecular & Cellular BiologyPathologyBaylor College of MedicineWEEI-CHINLINWEEI-CHIN LIN0.000000000000000.000000000000001687LIN, WEEI-CHINProfessorKANGLIUKANG LIU0.000000000000000.000000000000001707LIU, KANGInstructorKEITHCHANKEITH CHAN29.70508570000000-95.401808700000001603CHAN, KEITHAdjunct Associate ProfessorBENJAMINMUSHERBENJAMIN MUSHER0.000000000000000.000000000000002196MUSHER, BENJAMINAssociate ProfessorCARLOSRAMOSCARLOS RAMOS0.000000000000000.000000000000002089RAMOS, CARLOSProfessorJENNYCHANGJENNY CHANG0.000000000000000.0000000000000066CHANG, JENNYAdjunct ProfessorMICHAELITTMANNMICHAEL ITTMANN0.000000000000000.000000000000002694ITTMANN, MICHAELProfessor1.371890.00549705340research areas4.102280.03266596coauthor of38.71416.8960160similar to1149selected publicationsD060588Chemicals & Drugs701040.95573LIM Domain Proteins31964753Liu K, Graves JD, Lee YJ, Lin FT, Lin WCMolecular and cellular biologyCell Cycle-Dependent Switch of TopBP1 Functions by Cdk2 and Akt. Mol Cell Biol. 2020 03 30; 40(8).Mol Cell Biol2020-03-30T00:00:002020Cell Cycle-Dependent Switch of TopBP1 Functions by Cdk2 and Akt.SHIUH-RONGHOSHIUH-RONG HO0.000000000000000.000000000000006118HO, SHIUH-RONGFaculty Cliniciantrue1ProfessorProfessorAuthorship 1297045Authorship 1297062Authorship 1297078Authorship 1297082Authorship 1297091Authorship 1297101Authorship 1297113Authorship 1297124Authorship 1297134Authorship 1297143Authorship 1297152Authorship 1297163Authorship 1297174Authorship 1297182Authorship 1297207Authorship 1297212Authorship 12972210Authorship 1297351Authorship 1297366Authorship 1297371Authorship 1297381Authorship 129739120876301Lai YJ, Lin VT, Zheng Y, Benveniste EN, Lin FTMolecular and cellular biologyThe adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration. Mol Cell Biol. 2010 Dec; 30(23):5582-96.Mol Cell Biol2010-09-27T00:00:002010The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.21689746Lin VT, Lin FTCellular signallingTRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity. Cell Signal. 2011 Nov; 23(11):1691-7.Cell Signal2011-06-13T00:00:002011TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.18501721Lin FT, Lai YJBiochimica et biophysica actaRegulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions. Biochim Biophys Acta. 2008 Sep; 1781(9):558-62.Biochim Biophys Acta2008-05-03T00:00:002008Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions.22968304Kiss GN, Fells JI, Gupte R, Lee SC, Liu J, Nusser N, Lim KG, Ray RM, Lin FT, Parrill AL, S?megi B, Miller DD, Tigyi GMolecular pharmacologyVirtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Mol Pharmacol. 2012 Dec; 82(6):1162-73.Mol Pharmacol2012-09-11T00:00:002012Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions.22954454Brindley DN, Lin FT, Tigyi GJBiochimica et biophysica actaRole of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta. 2013 Jan; 1831(1):74-85.Biochim Biophys Acta2012-08-29T00:00:002012Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.19293149E S, Lai YJ, Tsukahara R, Chen CS, Fujiwara Y, Yue J, Yu JH, Guo H, Kihara A, Tigyi G, Lin FTThe Journal of biological chemistryLysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect. J Biol Chem. 2009 May 22; 284(21):14558-71.J Biol Chem2009-03-17T00:00:002009Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.12186555Lin FT, Chen W, Shenoy S, Cong M, Exum ST, Lefkowitz RJBiochemistryPhosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors. Biochemistry. 2002 Aug 27; 41(34):10692-9.Biochemistry2002-08-27T00:00:002002Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors.10617462Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FTScience (New York, N.Y.)Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science. 1999 Dec 24; 286(5449):2495-8.Science1999-12-24T00:00:001999Enhanced morphine analgesia in mice lacking beta-arrestin 2.10347142Lin FT, Miller WE, Luttrell LM, Lefkowitz RJThe Journal of biological chemistryFeedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases. J Biol Chem. 1999 Jun 04; 274(23):15971-4.J Biol Chem1999-06-04T00:00:001999Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases.9822622Lin FT, Daaka Y, Lefkowitz RJThe Journal of biological chemistrybeta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J Biol Chem. 1998 Nov 27; 273(48):31640-3.J Biol Chem1998-11-27T00:00:001998beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor.9388255Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, Pitcher JA, Lefkowitz RJThe Journal of biological chemistryClathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem. 1997 Dec 05; 272(49):31051-7.J Biol Chem1997-12-05T00:00:001997Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1.51Faculty Clinician32541040Graves JD, Lee YJ, Liu K, Li G, Lin FT, Lin WCProceedings of the National Academy of Sciences of the United States of AmericaE2F1 sumoylation as a protective cellular mechanism in oxidative stress response. Proc Natl Acad Sci U S A. 2020 06 30; 117(26):14958-14969.Proc Natl Acad Sci U S A2020-06-15T00:00:002020E2F1 sumoylation as a protective cellular mechanism in oxidative stress response.Authorship 1300101Authorship 1300111Authorship 130012133408251Xiao Y, Lin FT, Lin WCProceedings of the National Academy of Sciences of the United States of AmericaACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer. Proc Natl Acad Sci U S A. 2021 01 19; 118(3).Proc Natl Acad Sci U S A2021-01-19T00:00:002021ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.33556369Liu K, Graves JD, Lin FT, Lin WCThe Journal of biological chemistryOverexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer. J Biol Chem. 2021 Jan-Jun; 296:100382.J Biol Chem2021-02-05T00:00:002021Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.11459832Lin WC, Lin FT, Nevins JRGenes & developmentSelective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 2001 Jul 15; 15(14):1833-44.Genes Dev2001-07-15T00:00:002001Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.8090719Lin FT, Lane MDProceedings of the National Academy of Sciences of the United States of AmericaCCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci U S A. 1994 Sep 13; 91(19):8757-61.Proc Natl Acad Sci U S A1994-09-13T00:00:001994CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program.8415748Lin FT, MacDougald OA, Diehl AM, Lane MDProceedings of the National Academy of Sciences of the United States of AmericaA 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci U S A. 1993 Oct 15; 90(20):9606-10.Proc Natl Acad Sci U S A1993-10-15T00:00:001993A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity.1373117Lin FT, Lane MDGenes & developmentAntisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev. 1992 Apr; 6(4):533-44.Genes Dev1992-04-01T00:00:001992Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes.Authorship 10247613Authorship 10247622Authorship 10247635Authorship 10247644Authorship 10247652Authorship 10247661Authorship 10247674Authorship 10247682Authorship 1024770512944399Wu JH, Peppel K, Nelson CD, Lin FT, Kohout TA, Miller WE, Exum ST, Freedman NJThe Journal of biological chemistryThe adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor. J Biol Chem. 2003 Nov 07; 278(45):44238-45.J Biol Chem2003-08-27T00:00:002003The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor.12065593Huttenrauch F, Nitzki A, Lin FT, H?ning S, Oppermann MThe Journal of biological chemistryBeta-arrestin binding to CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites and involves a conserved Asp-Arg-Tyr sequence motif. J Biol Chem. 2002 Aug 23; 277(34):30769-77.J Biol Chem2002-06-13T00:00:002002Beta-arrestin binding to CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites and involves a conserved Asp-Arg-Tyr sequence motif.21527517Zheng Y, Qin H, Frank SJ, Deng L, Litchfield DW, Tefferi A, Pardanani A, Lin FT, Li J, Sha B, Benveniste ENBloodA CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. Blood. 2011 Jul 07; 118(1):156-66.Blood2011-04-28T00:00:002011A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway.true1Assistant ProfessorAssistant Professor34400221Ho SR, Lee YC, Ittmann MM, Lin FT, Chan KS, Lin WCCancer lettersRNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis. Cancer Lett. 2021 11 01; 520:344-360.Cancer Lett2021-08-13T00:00:002021RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis.Authorship 10320514true1Faculty ClinicianFaculty Clinician36469785Lin WC, Lin FTProceedings of the National Academy of Sciences of the United States of AmericaSuper-enhanced MARCO variant drives triple-negative breast cancer progression. Proc Natl Acad Sci U S A. 2022 12 13; 119(50):e2217953119.Proc Natl Acad Sci U S A2022-12-05T00:00:002022Super-enhanced MARCO variant drives triple-negative breast cancer progression.true1Adjunct ProfessorAdjunct ProfessorAuthorship 10770302true1Adjunct Associate ProfessorAdjunct Associate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 29658524820414Xiao Y, Lin VY, Ke S, Lin GE, Lin FT, Lin WCMolecular and cellular biology14-3-3t promotes breast cancer invasion and metastasis by inhibiting RhoGDIa. Mol Cell Biol. 2014 Jul; 34(14):2635-49.Mol Cell Biol2014-07-01T00:00:00201414-3-3t promotes breast cancer invasion and metastasis by inhibiting RhoGDIa.Authorship 1434693Authorship 1434702Authorship 1434713Authorship 1434726Authorship 1434733Authorship 1434747Authorship 1434753Authorship 1434762Authorship 1434772Authorship 143478311278469Cong M, Perry SJ, Lin FT, Fraser ID, Hu LA, Chen W, Pitcher JA, Scott JD, Lefkowitz RJThe Journal of biological chemistryRegulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem. 2001 May 04; 276(18):15192-9.J Biol Chem2001-01-22T00:00:002001Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79.11171997Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJProceedings of the National Academy of Sciences of the United States of Americabeta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1601-6.Proc Natl Acad Sci U S A2001-02-06T00:00:002001beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking.11130073Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MGNatureMu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 2000 Dec 07; 408(6813):720-3.Nature2000-12-07T00:00:002000Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.11090355McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJScience (New York, N.Y.)Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science. 2000 Nov 24; 290(5496):1574-7.Science2000-11-24T00:00:002000Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.10196135McDonald PH, Cote NL, Lin FT, Premont RT, Pitcher JA, Lefkowitz RJThe Journal of biological chemistryIdentification of NSF as a beta-arrestin1-binding protein. Implications for beta2-adrenergic receptor regulation. J Biol Chem. 1999 Apr 16; 274(16):10677-80.J Biol Chem1999-04-16T00:00:001999Identification of NSF as a beta-arrestin1-binding protein. Implications for beta2-adrenergic receptor regulation.9924018Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJScience (New York, N.Y.)Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999 Jan 29; 283(5402):655-61.Science1999-01-29T00:00:001999Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.9145918M?nard L, Ferguson SS, Zhang J, Lin FT, Lefkowitz RJ, Caron MG, Barak LSMolecular pharmacologySynergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization. Mol Pharmacol. 1997 May; 51(5):800-8.Mol Pharmacol1997-05-01T00:00:001997Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.8680485Lane MD, Lin FT, MacDougald OA, Vasseur-Cognet MInternational journal of obesity and related metabolic disorders : journal of the International Association for the Study of ObesityControl of adipocyte differentiation by CCAAT/enhancer binding protein alpha (C/EBP alpha). Int J Obes Relat Metab Disord. 1996 Mar; 20 Suppl 3:S91-6.Int J Obes Relat Metab Disord1996-03-01T00:00:001996Control of adipocyte differentiation by CCAAT/enhancer binding protein alpha (C/EBP alpha).8034662MacDougald OA, Cornelius P, Lin FT, Chen SS, Lane MDThe Journal of biological chemistryGlucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein alpha and delta genes in 3T3-L1 adipocytes and white adipose tissue. J Biol Chem. 1994 Jul 22; 269(29):19041-7.J Biol Chem1994-07-22T00:00:001994Glucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein alpha and delta genes in 3T3-L1 adipocytes and white adipose tissue.25400145Chowdhury P, Lin GE, Liu K, Song Y, Lin FT, Lin WCNature communicationsTargeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy. Nat Commun. 2014 Nov 17; 5:5476.Nat Commun2014-11-17T00:00:002014Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.Authorship 1535735